Geovax Labs Inc. (GOVX) NASDAQ
$1.72 0.02 (1.18%)
Market Cap: $3.97M
As of 05/15/24 04:00 PM EDT. Market closed.
Geovax Labs Inc. (GOVX)
NASDAQ
$1.72
0.02 (1.18%)
Market Cap: $3.97M
As of 05/15/24 04:00 PM EDT. Market closed.
Add to Portfolio
geovax labs, inc., (otcqb: govx) is a clinical-stage biotechnology company developing human vaccines against infectious diseases using our modified vaccinia ankara - virus-like particle (mva-vlp) vaccine platform. our development programs are focused on preventive vaccines against hiv, zika virus, hemorrhagic fever viruses (ebola, sudan, marburg, and lassa), and malaria, as well as therapeutic ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
David Dodd
Full Time Employees
26
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
David Dodd
Full Time Employees
26
URL
Address
11465 Johns Creek Pkwy Ste 400, Suite 380, Georgia, Smyrna, 30080.
PRICE CHART FOR GEOVAX LABS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.74
Previous Close
$1.70
Days Range
$1.68 - $1.76
52 week range
$1.38 - $11.54
Volume
73,808
Avg. Volume (30 days)
34,741
Market Cap
$3.97M
Dividend Yield
-
P/E
-
Shares Outstanding
2,308,309
Open
$1.74
Previous Close
$1.70
Days Range
$1.68 - $1.76
52 week range
$1.38 - $11.54
Volume
73,808
Avg. Volume (30 days)
34,741
Market Cap
$3.97M
Dividend Yield
-
P/E
-
Shares Outstanding
2,308,309
FINANCIAL STATEMENTS FOR GEOVAX LABS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR GEOVAX LABS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| DODD DAVID A | President, CEO | Feb 22, 2024 | Buy | $2.27 | 8,209 | 18,663 | 18,661 | Feb 22, 2024, 04:41 PM |
| DODD DAVID A | President, CEO | Feb 21, 2024 | Buy | $2.15 | 520 | 1,118 | 10,452 | Feb 22, 2024, 04:41 PM |
| Reynolds Mark | CFO | Feb 07, 2024 | Buy | $2.77 | 2,000 | 5,540 | 7,213 | Feb 07, 2024, 04:43 PM |
| McKee Kelly T. Jr. | Chief Medical Officer | Dec 22, 2023 | Buy | $0.36 | 6,944 | 2,500 | 35,782 | Dec 26, 2023, 03:51 PM |
| McKee Kelly T. Jr. | Chief Medical Officer | Sep 25, 2023 | Buy | $0.52 | 9,653 | 5,020 | 28,838 | Sep 27, 2023, 04:33 PM |
| DODD DAVID A | President, CEO | Aug 25, 2023 | Buy | $0.57 | 35,087 | 20,000 | 148,957 | Aug 28, 2023, 04:05 PM |
| Reynolds Mark | CFO | Aug 18, 2023 | Buy | $0.52 | 10,000 | 5,179 | 78,184 | Aug 21, 2023, 08:39 AM |
| DODD DAVID A | President, CEO | Apr 24, 2023 | Buy | $0.64 | 32,000 | 20,445 | 113,870 | Apr 25, 2023, 03:13 PM |
| Reynolds Mark | CFO | Apr 20, 2023 | Buy | $0.63 | 8,000 | 5,040 | 68,184 | Apr 21, 2023, 08:38 AM |
| CHASE RANDAL D | Director | Sep 21, 2022 | Buy | $1.10 | 10,000 | 11,000 | 36,613 | Sep 23, 2022, 11:24 AM |
| Sharkey John W. | VP, Business Development | Jul 01, 2022 | Buy | $0.82 | 1,000 | 820 | 2,860 | Jul 05, 2022, 03:10 PM |
| McKee Kelly T. Jr. | Chief Medical Officer | Jun 27, 2022 | Buy | $1.12 | 4,464 | 5,000 | 19,185 | Jun 28, 2022, 02:59 PM |
| CHASE RANDAL D | Director | Jun 21, 2022 | Buy | $1.21 | 10,000 | 12,100 | 26,613 | Jun 22, 2022, 08:53 AM |
| McKee Kelly T. Jr. | Chief Medical Officer | May 05, 2022 | Buy | $0.72 | 9,722 | 7,000 | 14,721 | May 06, 2022, 11:13 AM |
| Reynolds Mark | CFO | Sep 29, 2020 | Buy | $5.00 | 60,184 | 300,920 | 60,184 | Sep 29, 2020, 06:29 PM |
| DODD DAVID A | President, CEO | Sep 29, 2020 | Buy | $5.00 | 81,870 | 409,350 | 81,870 | Sep 29, 2020, 06:28 PM |
| MCNALLY ROBERT T | Director | Sep 29, 2020 | Buy | $5.00 | 53,925 | 269,625 | 53,925 | Sep 29, 2020, 06:28 PM |
| SPENCER JOHN N JR | Director | Sep 29, 2020 | Buy | $5.00 | 21,024 | 105,120 | 21,024 | Sep 29, 2020, 06:27 PM |
| Kollintzas Dean G | Director | Sep 29, 2020 | Buy | $5.00 | 11,987 | 59,935 | 11,987 | Sep 29, 2020, 06:26 PM |
| CHASE RANDAL D | Director | Sep 29, 2020 | Buy | $5.00 | 16,613 | 83,065 | 16,613 | Sep 29, 2020, 06:19 PM |
| CHASE RANDAL D | Director | May 05, 2015 | Buy | $0.19 | 10,000 | 1,899 | 40,000 | May 05, 2015, 05:36 PM |
| Reynolds Mark | CFO | Apr 23, 2015 | Buy | $0.18 | 10,000 | 1,780 | 66,000 | Apr 23, 2015, 01:05 PM |
| Reynolds Mark | CFO | Apr 22, 2015 | Buy | $0.17 | 20,000 | 3,435 | 56,000 | Apr 23, 2015, 01:05 PM |
| SPENCER JOHN N JR | Director | Apr 20, 2015 | Buy | $0.17 | 18,000 | 3,015 | 46,625 | Apr 20, 2015, 01:17 PM |
| CHASE RANDAL D | Director | Apr 20, 2015 | Buy | $0.17 | 30,000 | 5,100 | 30,000 | Apr 20, 2015, 01:17 PM |
| Reynolds Mark | CFO | Jan 31, 2012 | Buy | $0.67 | 15,000 | 10,050 | 36,000 | Feb 01, 2012, 03:47 PM |
| Antebi Steven S. | Director | Jan 16, 2012 | Buy | $0.67 | 30,000 | 20,100 | 30,000 | Jan 17, 2012, 09:06 AM |
| SPENCER JOHN N JR | Director | Dec 30, 2011 | Buy | $0.67 | 14,925 | 10,000 | 28,625 | Jan 04, 2012, 04:07 PM |
| Kollintzas Dean G | Director | Dec 30, 2011 | Buy | $0.67 | 14,925 | 10,000 | 14,925 | Jan 04, 2012, 04:06 PM |
| DODD DAVID A | Director | Dec 30, 2011 | Buy | $0.67 | 112,000 | 75,040 | 127,725 | Jan 04, 2012, 04:05 PM |
| ROBINSON HARRIET L | Chief Scientific Officer | Dec 30, 2011 | Buy | $0.67 | 149,254 | 100,000 | 1,201,226 | Jan 04, 2012, 04:05 PM |
| MCNALLY ROBERT T | President/CEO | Dec 30, 2011 | Buy | $0.67 | 29,850 | 20,000 | 29,850 | Jan 04, 2012, 04:05 PM |
| Reynolds Mark | CFO | Dec 30, 2011 | Buy | $0.67 | 15,000 | 10,050 | 21,000 | Jan 04, 2012, 03:57 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| DODD DAVID A | President, CEO | 02/22/2024 | 18,663 |
| DODD DAVID A | President, CEO | 02/21/2024 | 1,118 |
| Reynolds Mark | CFO | 02/07/2024 | 5,540 |
| McKee Kelly T. Jr. | Chief Medical Officer | 12/22/2023 | 2,500 |
| McKee Kelly T. Jr. | Chief Medical Officer | 09/25/2023 | 5,020 |
| DODD DAVID A | President, CEO | 08/25/2023 | 20,000 |
| Reynolds Mark | CFO | 08/18/2023 | 5,179 |
| DODD DAVID A | President, CEO | 04/24/2023 | 20,445 |
| Reynolds Mark | CFO | 04/20/2023 | 5,040 |
| CHASE RANDAL D | Director | 09/21/2022 | 11,000 |
| Sharkey John W. | VP, Business Development | 07/01/2022 | 820 |
| McKee Kelly T. Jr. | Chief Medical Officer | 06/27/2022 | 5,000 |
| CHASE RANDAL D | Director | 06/21/2022 | 12,100 |
| McKee Kelly T. Jr. | Chief Medical Officer | 05/05/2022 | 7,000 |
| Reynolds Mark | CFO | 09/29/2020 | 300,920 |
| DODD DAVID A | President, CEO | 09/29/2020 | 409,350 |
| MCNALLY ROBERT T | Director | 09/29/2020 | 269,625 |
| SPENCER JOHN N JR | Director | 09/29/2020 | 105,120 |
| Kollintzas Dean G | Director | 09/29/2020 | 59,935 |
| CHASE RANDAL D | Director | 09/29/2020 | 83,065 |
| CHASE RANDAL D | Director | 05/05/2015 | 1,899 |
| Reynolds Mark | CFO | 04/23/2015 | 1,780 |
| Reynolds Mark | CFO | 04/22/2015 | 3,435 |
| SPENCER JOHN N JR | Director | 04/20/2015 | 3,015 |
| CHASE RANDAL D | Director | 04/20/2015 | 5,100 |
| Reynolds Mark | CFO | 01/31/2012 | 10,050 |
| Antebi Steven S. | Director | 01/16/2012 | 20,100 |
| SPENCER JOHN N JR | Director | 12/30/2011 | 10,000 |
| Kollintzas Dean G | Director | 12/30/2011 | 10,000 |
| DODD DAVID A | Director | 12/30/2011 | 75,040 |
| ROBINSON HARRIET L | Chief Scientific Officer | 12/30/2011 | 100,000 |
| MCNALLY ROBERT T | President/CEO | 12/30/2011 | 20,000 |
| Reynolds Mark | CFO | 12/30/2011 | 10,050 |
Load More Insider Transactions
FUNDS WITH A POSITION IN GEOVAX LABS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 413,444 | 0% | Exited | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 172,895 | 0.00001% | Exited | Other |
| RENAISSANCE TECHNOLOGIES LLC | 28,700 | 0.00002% | Exited | Other |
| BLACKROCK INC. | 27,565 | 0% | New | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 11,161 | 0% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR GEOVAX LABS INC
STOCK BUYBACKS FOR GEOVAX LABS INC
Period of Report: 09/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2023
0.38%
1Q
03/31/2023
0.78%
2Q
09/30/2022
13.14%
4Q
BUYBACK ANNOUNCEMENT(S) FOR GEOVAX LABS INC
LOADING...